Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
25.30
-0.74 (-2.84%)
Sep 9, 2026, 4:00 PM EDT

SHA:603207 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
192.22207.49205.27203.63175.18126.27
Depreciation & Amortization
4.042.682.813.233.654.17
Other Amortization
-0.010.110.230.290.250.24
Loss (Gain) From Sale of Assets
-0.1-0.11---0-
Asset Writedown & Restructuring Costs
----0.270.06
Loss (Gain) From Sale of Investments
---0.02-2.25-2.96-2.83
Stock-Based Compensation
3.712.910.791.994.0843.78
Provision & Write-off of Bad Debts
0.131.850.220.171.37-0.71
Other Operating Activities
-0.4-0.360.10.130.050.08
Change in Accounts Receivable
-30.08-48.72-6.76-4.39-33.6812.74
Change in Inventory
-18.76-24.164.617.2-4.12-13.25
Change in Accounts Payable
20.4320.435.45-9.15-6.639.51
Operating Cash Flow
168.27160.8212.21200.26137.2179.51
Operating Cash Flow Growth
-16.14%-24.23%5.97%45.96%-23.57%1.37%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-84.9-54.24-83.94-80.15-61.59-12.48
Sale of Property, Plant & Equipment
0.110.11---0.46
Investment in Securities
145.86356-450.1107.2754.02-97.57
Other Investing Activities
3.054.143.09-0.720.95.19
Investing Cash Flow
64.11306.01-530.9526.4-6.67-104.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1.121.65---
Total Debt Issued
1.121.121.65---
Long-Term Debt Repaid
--0.4-0.23-0.45--
Lease Payments
-0.4-0.4-0.23-0.45--
Net Debt Issued (Repaid)
0.720.721.43-0.45--
Issuance of Common Stock
1.458.38472.361.98-3.4
Common Dividends Paid
-132.12-353.23---111.39-84.56
Other Financing Activities
6.56-5.33-10.73-4.3-5.28-1.2
Financing Cash Flow
-123.4-349.47463.06-2.78-116.67-82.36

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
108.99117.34144.31223.8713.85-7.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
83.37106.56128.27120.1175.61167.03
Free Cash Flow Growth
-34.11%-16.93%6.79%58.86%-54.73%20.59%
Free Cash Flow Margin
15.51%20.29%27.03%25.45%16.55%41.57%
Free Cash Flow Per Share
0.520.660.961.000.631.39
Levered Free Cash Flow
20.2514.87114.93106.55-37.4211.19
Unlevered Free Cash Flow
20.2714.89114.95106.58-37.36211.25
Free Cash Flow After Leases
82.97106.15128.04119.6675.61167.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
83.2186.1262.8681.7371.6459.18
Change in Working Capital
-31.32-53.772.79-6.92-44.78.44